At a glance
- Originator Organon
- Class Class Ic antiarrhythmics; Estrenes; Small molecules
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 08 Jan 2001 Discontinued-Preclinical for Arrhythmias in Netherlands (Unknown route)
- 06 Aug 1997 Preclinical development for Arrhythmias in Netherlands (Unknown route)